ATLANTIC CITY, New Jersey (Reuters) - A New Jersey jury on Tuesday found that Swiss drugmaker Roche Holding AG failed to adequately warn a patient of the bowel disease risks associated with its acne medicine Accutane and awarded him $2. The jury, during its third day of deliberations, also found that the failure to warn was a major contributing cause of his contracting the bowel disease and awarded the plaintiff an additional $119,000 to cover medical expenses. However, in considering New Jersey state consumer fraud charges, the jury in New Jersey Superior Court found for Roche, saying the company did not misrepresent or conceal Accutane's bowel risks prior to June 1995. McCarrell, who has three children aged between 10 months and 7 years, said after the verdict that he will now be able to afford better medical treatment and to take time off from work, unpaid if necessary, to deal with his condition. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. read more
Technorati Tags: jersey, reuters, bowel, found, jury, 1995, acne news
This entry was posted
on Wednesday, May 30th, 2007 at 8:35 pm and is filed under Acne News.
You can follow any responses to this entry through the RSS 2.0 feed.
Responses are currently closed, but you can trackback from your own site.
Loading ...
